MP
META Pharmaceuticals develops small molecule therapeutics for autoimmune diseases. Their platform focuses on novel drug targets to create treatments that modulate immune responses and reduce inflammation.
Updated 15 months ago
Funding
Funding not disclosed
X
Funding rounds are not available yet.
Founders
Product
Features
- META Pharmaceuticals develops small molecule therapeutics for autoimmune diseases. Their platform focuses on novel drug targets to create treatments that modulate immune responses and reduce inflammation.